Organon & Co. Common Stock (OGN)
OGN trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$13.77
0.00% on the day
Market cap
$3.6B
Mid cap
Revenue · 2025
$6.2B
-2.9% on 2024
Net income · 2025
$187.0M
3.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | OGN on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001821825 |
| SEC industry code | Pharmaceutical Preparations |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $6.2B |
| Net income | $187.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | 3.0% |
| Operating margin | Operating income not reported |
| Revenue growth | -2.9% |
| Cash | $574.0M |
| Total assets | $12.9B |
| P/E (computed) | 19.3× |
| P/S (computed) | 0.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | DRS | 2020-11-02 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-07-31 |
| Latest current report FORM 8-K | 8-K | 2026-07-31 |
| Latest proxy | DEFA14A | 2026-07-17 |
Source: SEC EDGAR submissions feed, 459 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.2% |
| 1 month | +0.8% |
| 3 months | +2.0% |
| Year to date | +92.0% |
| 1 year | +43.4% |
| From 52-week high | -0.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TLX | Telix Pharmaceuticals Limited | $10.92 | -3.28% | $3.7B |
| TNGX | Tango Therapeutics Inc. | $22.22 | -8.07% | $3.7B |
| LEGN | Legend Biotech Corporation | $17.88 | +0.45% | $3.5B |
| AMLX | Amylyx Pharmaceuticals Inc. | $26.85 | -2.29% | $3.4B |
| VKTX | Viking Therapeutics Inc. | $26.65 | -5.96% | $3.3B |
| XENE | Xenon Pharmaceuticals Inc. Common Shares | $34.42 | -3.88% | $3.3B |
| EWTX | Edgewise Therapeutics Inc. | $36.28 | -5.64% | $3.9B |
| IDYA | IDEAYA Biosciences Inc. | $34.26 | -4.99% | $3.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier